<format type="yaml">{report_id: string, report_date: date, patient_details: {patient_id: string, age_at_reaction: number optional, gender: string, relevant_history: list[string]}, suspected_drugs: list[{drug_name: string, drug_class: string optional, dosage: string, route_of_administration: string, start_date: date, end_date: date optional, indication_for_use: string}], adverse_reactions: list[{symptom_name: string, onset_date: date, severity: string, outcome: string, intervention_required: boolean, intervention_details: string optional}], causality_assessment: {naranjo_score: number optional, assessment_conclusion: string, dechallenge_rechallenge: string}, reporting_facility: string, reporter_type: string, notes: string optional}</format> <data>PHARMACOVIGILANCE CASE REPORT - CONFIDENTIAL
Report Identifier: ADR-2025-439
Date of Submission: 2025-02-27

This report was submitted by a Physician from Romero-Stein Medical Center concerning patient ANON-PX-8334. The subject is an adult other with a significant medical history including atrial fibrillation, migraines. The facility's standard operating procedure for ADR reporting was followed, and all patient data has been anonymized. The patient chart was reviewed for comorbidities. 

Current medication review revealed the following suspected agent(s): Gabapentin administered via the Subcutaneous route at a dosage of 211mg, initiated on 2025-01-18 for Neuropathic pain with the course ongoing.

On approximately 2025-02-13, the patient began to manifest an adverse event. The primary symptoms noted in the clinical log were Nausea, Headache, Somnolence. The Nausea was classified as Life-threatening in severity. This necessitated clinical intervention. The documented action was: Prescribed number and advised finish. The current patient status regarding this symptom is 'Not Recovered'. The Headache was classified as Life-threatening in severity. This necessitated clinical intervention. The current patient status regarding this symptom is 'Not Recovered'. The Somnolence was classified as Moderate in severity. This necessitated clinical intervention. The documented action was: Prescribed board and advised agency. The current patient status regarding this symptom is 'Unknown'. 

CAUSALITY ASSESSMENT:
An evaluation of causality was performed. A Naranjo score of 8 was calculated, The assessment concluded the relationship was 'Probable'. Dechallenge/Rechallenge status was noted as: 'Positive dechallenge'. The on-site pharmacist concurred with the assessment during a routine case review. 

Reporter's Narrative Summary: Place partner road. Produce threat item manage rest watch. Executive we there out.</data>
report_id: ADR-2025-439
report_date: '2025-02-27'
patient_details:
  patient_id: ANON-PX-8334
  gender: Other
  relevant_history:
  - atrial fibrillation
  - migraines
suspected_drugs:
- drug_name: Gabapentin
  dosage: 211mg
  route_of_administration: Subcutaneous
  start_date: '2025-01-18'
  indication_for_use: Neuropathic pain
adverse_reactions:
- symptom_name: Nausea
  onset_date: '2025-02-13'
  severity: Life-threatening
  outcome: Not Recovered
  intervention_required: true
  intervention_details: Prescribed number and advised finish.
- symptom_name: Headache
  onset_date: '2025-02-13'
  severity: Life-threatening
  outcome: Not Recovered
  intervention_required: true
- symptom_name: Somnolence
  onset_date: '2025-02-13'
  severity: Moderate
  outcome: Unknown
  intervention_required: true
  intervention_details: Prescribed board and advised agency.
causality_assessment:
  assessment_conclusion: Probable
  dechallenge_rechallenge: Positive dechallenge
  naranjo_score: 8
reporting_facility: Romero-Stein Medical Center
reporter_type: Physician
notes: Place partner road. Produce threat item manage rest watch. Executive we there
  out.
